CD40 Ligand-Modified Chimeric Antigen Receptor (CAR) T Cells Enhance Antitumor Function by Eliciting an Endogenous Antitumor Response

相似書籍

• Enhancing Antitumor Efficacy of Chimeric Antigen Receptor T Cells Through Constitutive CD40L Expression
  由: Curran, Kevin J, et al.
  出版: (2015)
• CD103(+) cDC1 and endogenous CD8(+) T cells are necessary for improved CD40L-overexpressing CAR T cell antitumor function
  由: Kuhn, Nicholas F., et al.
  出版: (2020)
• Cytokine IL-36γ Improves CAR T Cell Functionality and Induces Endogenous Anti-Tumor Response
  由: Li, Xinghuo, et al.
  出版: (2020)
• At the Bench: Chimeric antigen receptor (CAR) T cell therapy for the treatment of B cell malignancies
  由: Daniyan, Anthony F. O., et al.
  出版: (2016)
• Armored CAR T cells enhance antitumor efficacy and overcome the tumor microenvironment
  由: Yeku, Oladapo O., et al.
  出版: (2017)